![ORCID Icon]({"type":"image","src":"/templates/jsp/_style2/_tandf/images/orcid.svg"} "ORCID Icon"){kind=small}
https://orcid.org/0000-0001-5074-0005
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![Publish Open Access Finland]({"type":"image" , "src" : "/sda/110396/JournalAd-OA-Agreements.gif"})
Abstract
Purpose
This study analyzed the safety of myomectomy during the cesarean section (CS).
Methods
Pregnant women who underwent myomectomy during CS in a tertiary center between January 2015 and November 2019 were included in the study in Group A, and pregnant women who did not have myoma and who underwent only CS were included in the study in Group B. The following information was obtained from patient files in hospital archives and was then recorded and compared: age, gravidity, parity, gestational week, characteristics of the myomas (i.e., location, size, number, and type), duration of surgery, perioperative complications, need for blood transfusion, preoperative and postoperative hemoglobin (Hb) values, duration of surgery, and hospital stay duration.
Results
A total of 83 patients underwent CS plus myomectomy (Group A), and 80 patients (without myoma) underwent only CS (Group B).There were no statistically significant differences between the groups in terms of preoperative and postoperative Hb values or blood transfusion rates (p > 0.05). Hospitalization and surgery duration were significantly higher in the group that underwent CS myomectomy (p = 0.001 and p = 0.001, respectively). The mean myoma size was 8.3 ± 4.1 cm in Group A. There was a statistically significant and inverse correlation between the size of the myoma and the delivery week (p = 0.035). There was a statistically significant and positive correlation between the myoma size and hospital stay (p = 0.01).
Conclusion
Myomectomy during CS is safe and can be applied regardless of the location, size, type, and number of myomas. However, to make myomectomy routine during CS, multi-center studies that include more cases are needed.
Acknowledgments
We have no acknowledgments to be mentioned. All authors declare that they received no funding for this study.
Disclosure statement
The authors declare that they have no conflict of interest. Authors declare that no funding or any type of sponsorships was received.
Authorship credits
The authors declare that they are qualified for authorship and have participated sufficiently in the work to take public responsibility for appropriate portions of the content. The authors declare that they made a substantial contribution to the concept or design of the work; or acquisition, analysis, or interpretation of data, drafted article or revised it critically for important intellectual content, approved the version to be published and each author have participated sufficiently in the work and take public responsibility for appropriate portions of the content.
Authors’ contributions
Mehmet Sakinci: Study design, data analysis, manuscript writing, critical revision.
Gokce Turan: Study design, data analysis, manuscript writing.
Cem Yasar Sanhal: Study conception and design, acquisition of data.
Yunus Yildiz: Acquisition of data, ethics approval.
Aygun Hamidova: Acquisition of data.
Fatma Ceren Guner: Acquisition of data.
Alime Buyuk: Acquisition of data.
Nasuh Utku Dogan: Acquisition of data.
Şafak Olgan: Study conception and design.